{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:56:11Z","timestamp":1792439771725,"version":"4.5.0"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Molecular subtyping of bladder cancer (BCa) using bulk transcriptomic data is hindered by tumor microenvironment (TME) contamination and intra-tumoral heterogeneity. These factors also contribute to variable responses to immune checkpoint inhibitor (ICI) therapy. Single-cell RNA sequencing offers a high-resolution approach to overcome these limitations by enabling tumor-specific analysis and improving therapeutic target identification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>\n                      We constructed a large multicenter single-cell atlas of BCa by integrating nine cohorts comprising 123 samples and 842 127 cells. Tumor epithelial cells (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =\u00a0265 962) were identified via copy number variation (CNV) analysis using inferCNV. Pseudobulk RNA profiles were generated to simulate conventional bulk samples (Pseudobulk\n                      <jats:sub>all<\/jats:sub>\n                      ) and purified tumor profiles (Pseudobulk\n                      <jats:sub>tumor<\/jats:sub>\n                      ), enabling systematic evaluation of bulk-based classifiers. Inter-tumoral and intra-tumoral heterogeneity programs were defined based on transcriptional profiles and validated through in vitro and\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      experiments. Additionally, we cross-analyzed five immunotherapy datasets encompassing 13 immune response phenotypes to identify molecular features associated with therapeutic resistance and sensitivity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Unsupervised clustering identified 11 major cell types and 55 non-epithelial subtypes, with TME heterogeneity driven by tissue origin and malignancy status. Existing molecular classifiers UNC (University of North Carolina at Chapel Hill) showed compromised concordance between Pseudobulk\n                      <jats:sub>all<\/jats:sub>\n                      and Pseudobulk\n                      <jats:sub>tumor<\/jats:sub>\n                      , particularly in stroma-rich samples. We defined three inter-tumoral (GE\n                      <jats:sub>inter<\/jats:sub>\n                      2\u20134) subtypes with distinct CNV and transcription factor signatures that remained stable even at low tumor purity. Seven intra-tumoral (GE\n                      <jats:sub>intra<\/jats:sub>\n                      ) programs captured key biological states, including an EMT\/Stem-like module associated with immunosuppression and ICI resistance. Mechanistically, TGF-\u03b21 induced expression of EMT\/Stem-like genes (e.g.,\n                      <jats:italic toggle=\"yes\">PTHLH<\/jats:italic>\n                      ), while Pthlh knockdown synergized with anti-PD-L1 therapy in murine models by enhancing T cell cytotoxicity without altering T cell infiltration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      This study provides a robust single-cell framework for resolving inter- and intra-tumoral heterogeneity in BCa, overcoming limitations of bulk-based subtyping. The TGF-\u03b21-PTHLH axis contributes to ICI resistance, positioning\n                      <jats:italic toggle=\"yes\">PTHLH<\/jats:italic>\n                      as a promising therapeutic target. These findings offer new insights for improving immunotherapeutic strategies in BCa.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003830","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:01:09Z","timestamp":1770130869000},"page":"6005-6024","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Integrated multicenter single-cell atlas of bladder cancer reveals tumor heterogeneity associated with immunotherapy"],"prefix":"10.1097","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8799-812X","authenticated-orcid":false,"given":"Ziwei","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[{"name":"Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meimian","family":"Hua","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai First People\u2019s Hospital, Shanghai Jiaotong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidie","family":"Ying","sequence":"additional","affiliation":[{"name":"Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufeng","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhensheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxiong","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanliang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai First People\u2019s Hospital, Shanghai Jiaotong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"R1-20260417","doi-asserted-by":"crossref","first-page":"544\u201348","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"R2-20260417","doi-asserted-by":"crossref","first-page":"3857\u201366","DOI":"10.1158\/1078-0432.CCR-17-3451","article-title":"Interferon gamma messenger RNA signature in tumor biopsies predicts outcomes in patients with non-small cell lung carcinoma or urothelial cancer treated with durvalumab","volume":"24","author":"Higgs","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R3-20260417","doi-asserted-by":"crossref","first-page":"515\u201324","DOI":"10.1126\/science.ade2292","article-title":"CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers","volume":"381","author":"Bill","year":"2023","journal-title":"Science"},{"key":"R4-20260417","doi-asserted-by":"crossref","first-page":"598\u2013606","DOI":"10.1038\/s41586-023-06130-4","article-title":"Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours","volume":"618","author":"Gavish","year":"2023","journal-title":"Nature"},{"key":"R5-20260417","doi-asserted-by":"crossref","first-page":"101511","DOI":"10.1016\/j.xcrm.2024.101511","article-title":"A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response","volume":"5","author":"Xu","year":"2024","journal-title":"Cell Rep Med"},{"key":"R6-20260417","article-title":"Transparency in the reporting of Artificial Intelligence \u2013 the TITAN guideline","volume":"2","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R7-20260417","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12967-024-04860-1","article-title":"Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer","volume":"22","author":"Yuan","year":"2024","journal-title":"J Transl Med"},{"key":"R8-20260417","doi-asserted-by":"crossref","first-page":"818147","DOI":"10.3389\/fonc.2022.818147","article-title":"Single-cell transcriptome comparison of bladder cancer reveals its ecosystem","volume":"12","author":"Luo","year":"2022","journal-title":"Front Oncol"},{"key":"R9-20260417","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ccell.2024.02.002","article-title":"PDGFR\u03b1+ITGA11+ fibroblasts foster early-stage cancer lymphovascular invasion and lymphatic metastasis via ITGA11-SELE interplay","volume":"42","author":"Zheng","year":"2024","journal-title":"Cancer Cell"},{"key":"R10-20260417","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","article-title":"Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer","volume":"40","author":"Ma","year":"2022","journal-title":"Cancer Cell"},{"key":"R11-20260417","doi-asserted-by":"crossref","first-page":"1729\u201341","DOI":"10.1158\/1535-7163.MCT-22-0130","article-title":"Tumor-infiltrating myeloid cells confer de novo resistance to PD-L1 blockade through EMT-stromal and Tgf\u03b2-dependent mechanisms","volume":"21","author":"Yu","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"R12-20260417","doi-asserted-by":"crossref","first-page":"2099\u2013115","DOI":"10.1002\/ijc.33794","article-title":"Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer","volume":"149","author":"Lai","year":"2021","journal-title":"Int, J, Cancer"},{"key":"R13-20260417","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","article-title":"Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma","volume":"11","author":"Chen","year":"2020","journal-title":"Nat Commun"},{"key":"R14-20260417","first-page":"e00128","article-title":"A laboratory medicine best practices systematic review and meta-analysis of nucleic acid amplification tests (NAATs) and algorithms including NAATs for the diagnosis of clostridioides (Clostridium) difficile in adults","volume":"32","author":"Kraft","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"R15-20260417","doi-asserted-by":"crossref","first-page":"420\u201333","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"R16-20260417","doi-asserted-by":"crossref","first-page":"5646\u201354","DOI":"10.1158\/1078-0432.CCR-20-0401","article-title":"Noninvasive detection of urothelial carcinoma by cost-effective low-coverage whole-genome sequencing from urine-exfoliated cell DNA","volume":"26","author":"Zeng","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R17-20260417","doi-asserted-by":"crossref","first-page":"523\u201332","DOI":"10.1016\/j.eururo.2021.10.035","article-title":"Different responses to neoadjuvant chemotherapy in urothelial carcinoma molecular subtypes","volume":"81","author":"Sj\u00f6dahl","year":"2022","journal-title":"Eur Urol"},{"key":"R18-20260417","doi-asserted-by":"crossref","first-page":"3110\u201315","DOI":"10.1073\/pnas.1318376111","article-title":"Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology","volume":"111","author":"Damrauer","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-20260417","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1038\/s41598-018-22126-x","article-title":"A validation and extended description of the lund taxonomy for urothelial carcinoma using the TCGA cohort","volume":"8","author":"Marzouka","year":"2018","journal-title":"Sci Rep"},{"key":"R20-20260417","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2018.07.036","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"174","author":"Robertson","year":"2018","journal-title":"Cell"},{"key":"R21-20260417","doi-asserted-by":"crossref","first-page":"328\u201332","DOI":"10.1016\/j.eururo.2023.03.020","article-title":"Molecular urothelial tumor cell subtypes remain stable during metastatic evolution","volume":"85","author":"Cox","year":"2024","journal-title":"Eur Urol"},{"key":"R22-20260417","doi-asserted-by":"crossref","first-page":"1434378","DOI":"10.3389\/fcell.2024.1434378","article-title":"Integrins in cancer stem cells","volume":"12","author":"Gou","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"R23-20260417","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3389\/fonc.2020.00486","article-title":"Hypoxia-induced epithelial-mesenchymal transition in cancers: HIF-1\u03b1 and beyond","volume":"10","author":"Tam","year":"2020","journal-title":"Front Oncol"},{"key":"R24-20260417","doi-asserted-by":"crossref","first-page":"3892\u201399","DOI":"10.1158\/0008-5472.CAN-03-2904","article-title":"Akt stimulates aerobic glycolysis in cancer cells","volume":"64","author":"Elstrom","year":"2004","journal-title":"Cancer Res"},{"key":"R25-20260417","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s41419-018-0877-2","article-title":"TGF-\u03b21-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis"},{"key":"R26-20260417","doi-asserted-by":"crossref","first-page":"1706\u201314","DOI":"10.1038\/s41591-019-0628-7","article-title":"Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial","volume":"25","author":"Powles","year":"2019","journal-title":"Nat Med"},{"key":"R27-20260417","doi-asserted-by":"crossref","first-page":"432\u201337","DOI":"10.1038\/s41586-021-03642-9","article-title":"ctDNA guiding adjuvant immunotherapy in urothelial carcinoma","volume":"595","author":"Powles","year":"2021","journal-title":"Nature"},{"key":"R28-20260417","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/s41467-023-37568-9","article-title":"Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer","volume":"14","author":"Robertson","year":"2023","journal-title":"Nat Commun"},{"key":"R29-20260417","doi-asserted-by":"crossref","first-page":"1251\u201360","DOI":"10.1038\/s41416-021-01488-6","article-title":"Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience","volume":"125","author":"Rose","year":"2021","journal-title":"Br J Cancer"},{"key":"R30-20260417","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","article-title":"Large-scale public data reuse to model immunotherapy response and resistance","volume":"12","author":"Fu","year":"2020","journal-title":"Genome Med"},{"key":"R31-20260417","doi-asserted-by":"crossref","first-page":"1043\u201348","DOI":"10.1038\/ng1861","article-title":"A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers","volume":"38","author":"Carter","year":"2006","journal-title":"Nat Genet"},{"key":"R32-20260417","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-020-01820-7","article-title":"Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy","volume":"40","author":"Wang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"R33-20260417","doi-asserted-by":"crossref","first-page":"2125\u201333","DOI":"10.1002\/ijc.30646","article-title":"Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN-\u03b3 and induces NK cell-dependent lymphoma control without other immunotherapies","volume":"140","author":"P\u00f6tzl","year":"2017","journal-title":"Int, J, Cancer"},{"key":"R34-20260417","doi-asserted-by":"crossref","first-page":"963\u201375","DOI":"10.1038\/s41588-022-01100-4","article-title":"Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer","volume":"54","author":"Joanito","year":"2022","journal-title":"Nat Genet"},{"key":"R35-20260417","doi-asserted-by":"crossref","first-page":"448\u201359","DOI":"10.1093\/jnci\/djx243","article-title":"Prognostic power of a tumor differentiation gene signature for bladder urothelial carcinomas","volume":"110","author":"Mo","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R36-20260417","doi-asserted-by":"crossref","first-page":"152\u201365","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"key":"R37-20260417","doi-asserted-by":"crossref","first-page":"244ra91","DOI":"10.1126\/scitranslmed.3008970","article-title":"EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype","volume":"6","author":"Rebouissou","year":"2014","journal-title":"Sci Transl Med"},{"key":"R38-20260417","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer","volume":"171","author":"Puram","year":"2017","journal-title":"Cell"},{"key":"R39-20260417","doi-asserted-by":"crossref","first-page":"11\u201324","DOI":"10.1016\/j.humpath.2022.01.006","article-title":"Molecular pathology of the non-luminal Ba\/Sq-like and Sc\/NE-like classes of urothelial tumours: an integrated immunohistochemical analysis","volume":"122","author":"Bernardo","year":"2022","journal-title":"Hum Pathol"},{"key":"R40-20260417","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ccell.2022.10.008","article-title":"High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer","volume":"40","author":"Salcher","year":"2022","journal-title":"Cancer Cell"},{"key":"R41-20260417","doi-asserted-by":"crossref","first-page":"2078\u201383","DOI":"10.1073\/pnas.1120605109","article-title":"Three differentiation states risk-stratify bladder cancer into distinct subtypes","volume":"109","author":"Volkmer","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-20260417","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1038\/s41467-021-25103-7","article-title":"An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer","volume":"12","author":"Gouin","year":"2021","journal-title":"Nat Commun"},{"key":"R43-20260417","doi-asserted-by":"crossref","first-page":"176\u201386","DOI":"10.21037\/tau-22-538","article-title":"Identification and validation of immunohistochemical marker panels to predict the prognosis of muscle invasive bladder cancer","volume":"12","author":"Ying","year":"2023","journal-title":"Transl Androl Urol"},{"key":"R44-20260417","doi-asserted-by":"crossref","first-page":"898493","DOI":"10.3389\/fimmu.2022.898493","article-title":"IGFBP7 and the tumor immune landscape: a novel target for immunotherapy in bladder cancer","volume":"13","author":"Yi","year":"2022","journal-title":"Front Immunol"},{"key":"R45-20260417","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cell.2019.03.025","article-title":"Adaptive immune resistance emerges from tumor-initiating stem cells","volume":"177","author":"Miao","year":"2019","journal-title":"Cell"},{"key":"R46-20260417","doi-asserted-by":"crossref","first-page":"347\u201367","DOI":"10.1016\/j.ccell.2019.01.007","article-title":"Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance","volume":"35","author":"Cooper","year":"2019","journal-title":"Cancer Cell"},{"key":"R47-20260417","doi-asserted-by":"crossref","first-page":"704\u201315","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"R48-20260417","doi-asserted-by":"crossref","first-page":"617\u201339","DOI":"10.1016\/j.stem.2024.04.004","article-title":"Hallmarks of cancer stemness","volume":"31","author":"Loh","year":"2024","journal-title":"Cell Stem Cell"},{"key":"R49-20260417","doi-asserted-by":"crossref","first-page":"526\u201336","DOI":"10.1038\/s41568-021-00366-w","article-title":"Cancer stem cell-immune cell crosstalk in tumour progression","volume":"21","author":"Bayik","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"R50-20260417","doi-asserted-by":"crossref","first-page":"108597","DOI":"10.1016\/j.celrep.2020.108597","article-title":"Cancer stemness meets immunity: from mechanism to therapy","volume":"34","author":"Chen","year":"2021","journal-title":"Cell Rep"},{"key":"R51-20260417","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.stem.2020.06.022","article-title":"BMI1 inhibition eliminates residual cancer stem cells after PD1 blockade and activates antitumor immunity to prevent metastasis and relapse","volume":"27","author":"Jia","year":"2020","journal-title":"Cell Stem Cell"},{"key":"R52-20260417","doi-asserted-by":"crossref","first-page":"355\u201370","DOI":"10.1038\/s43018-022-00339-4","article-title":"LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer","volume":"3","author":"P\u00e9rez-N\u00fa\u00f1ez","year":"2022","journal-title":"Nat Cancer"},{"key":"R53-20260417","article-title":"Anti-PTHrP blockade limits CD8+ T-cell exhaustion in anti-cancer immunotherapy","author":"Mo\u00ebs","year":"2024","journal-title":"bioRxiv"},{"key":"R54-20260417","article-title":"Identification and validation of novel biomarkers affecting bladder cancer immunotherapy via machine learning and its association with M2 macrophages","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"R55-20260417","doi-asserted-by":"crossref","first-page":"105764","DOI":"10.1016\/j.isci.2022.105764","article-title":"SLC17A9-PTHLH-EMT axis promotes proliferation and invasion of clear renal cell carcinoma","volume":"26","author":"Li","year":"2023","journal-title":"iScience"},{"key":"R56-20260417","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1016\/j.cell.2025.07.004","article-title":"Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy","volume":"188","author":"Gong","year":"2025","journal-title":"Cell"},{"key":"R57-20260417","doi-asserted-by":"crossref","first-page":"1717\u201335","DOI":"10.1002\/hep.31792","article-title":"Cancer-associated fibroblast-mediated cellular crosstalk supports hepatocellular carcinoma progression","volume":"73","author":"Song","year":"2021","journal-title":"Hepatology"},{"key":"R58-20260417","doi-asserted-by":"crossref","first-page":"eaay1813","DOI":"10.1126\/science.aay1813","article-title":"Tumor-initiating cells establish an IL-33-TGF-\u03b2 niche signaling loop to promote cancer progression","volume":"369","author":"Taniguchi","year":"2020","journal-title":"Science"},{"key":"R59-20260417","doi-asserted-by":"crossref","first-page":"61\u201374","DOI":"10.1016\/j.cell.2013.06.005","article-title":"Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity","volume":"154","author":"Chaffer","year":"2013","journal-title":"Cell"},{"key":"R60-20260417","doi-asserted-by":"crossref","first-page":"197\u2013205","DOI":"10.1038\/cmi.2013.52","article-title":"Activation of the Ig I\u03b11 promoter by the transcription factor Ets-1 triggers Ig I\u03b11-C\u03b11 germline transcription in epithelial cancer cells","volume":"11","author":"Duan","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"R61-20260417","doi-asserted-by":"crossref","first-page":"100755","DOI":"10.1016\/j.omto.2023.100755","article-title":"New advances in cancer therapy targeting TGF-\u03b2 signaling pathways","volume":"31","author":"Shou","year":"2023","journal-title":"Mol Ther Oncolytics"},{"key":"R62-20260417","doi-asserted-by":"crossref","first-page":"2159\u201376","DOI":"10.1681\/ASN.2019040335","article-title":"Single-cell transcriptomic map of the human and mouse bladders","volume":"30","author":"Yu","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"R63-20260417","doi-asserted-by":"crossref","first-page":"114\u201322","DOI":"10.1016\/j.eururo.2023.06.007","article-title":"Updated overall survival by circulating tumor DNA status from the phase 3 IMvigor010 trial: adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma","volume":"85","author":"Powles","year":"2024","journal-title":"Eur Urol"},{"key":"R64-20260417","first-page":"3353\u201360","article-title":"Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study","volume":"36","author":"Necchi","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:06:37Z","timestamp":1776423997000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003830","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"2025-02-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}